Skip to main content
. 2014 May 8;7(Suppl 1):S8. doi: 10.1186/1755-8794-7-S1-S8

Figure 7.

Figure 7

FDA-approved and clinical therapeutic targets. Abbreviation - T2D - Type 2 Diabetes; Comparison of Gentrepid predicted targets for Type 2 diabetes targeted by FDA-approved and clinical trial drugs with targets obtained from the TTD database for Type 2 Diabetes. Three predicted therapeutic targets (HSD11B1, PPARA, NR3C1) targeted by drugs currently in clinical trials for T2D. In addition, PPARA is also targeted by FDA-approved drugs.

HHS Vulnerability Disclosure